Skip to main navigation Skip to search Skip to main content

MAGELLaN - Multicenter, rAndomized, parallel Group Efficacy and safety study for the prevention of venous thromboembolism in hospitalized medically iLL patients comparing rivaroxabaN with enoxaparin

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date05/1/10 → 11/10/10

Funding

  • Bayer Healthcare Pharmaceuticals Incorporated: $1,500.00